Cargando…

Synergistic antiviral effect of hydroxychloroquine and azithromycin in combination against SARS-CoV-2: What molecular dynamics studies of virus-host interactions reveal

The emergence of SARS-coronavirus-2 (SARS-CoV-2) has led to a global pandemic disease referred to as coronavirus disease 19 (COVID-19). Hydroxychloroquine (CLQ-OH)/azithromycin (ATM) combination therapy is currently being tested for the treatment of COVID-19, with promising results. However, the mol...

Descripción completa

Detalles Bibliográficos
Autores principales:	Fantini, Jacques, Chahinian, Henri, Yahi, Nouara
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier B.V. and International Society of Chemotherapy. 2020
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7219429/ https://www.ncbi.nlm.nih.gov/pubmed/32405156 http://dx.doi.org/10.1016/j.ijantimicag.2020.106020

Ejemplares similares

Structural and molecular modelling studies reveal a new mechanism of action of chloroquine and hydroxychloroquine against SARS-CoV-2 infection
por: Fantini, Jacques, et al.
Publicado: (2020)

Convergent Evolution Dynamics of SARS-CoV-2 and HIV Surface Envelope Glycoproteins Driven by Host Cell Surface Receptors and Lipid Rafts: Lessons for the Future
por: Fantini, Jacques, et al.
Publicado: (2023)

Infection-enhancing anti-SARS-CoV-2 antibodies recognize both the original Wuhan/D614G strain and Delta variants. A potential risk for mass vaccination?
por: Yahi, Nouara, et al.
Publicado: (2021)

Structural dynamics of SARS-CoV-2 variants: A health monitoring strategy for anticipating Covid-19 outbreaks
por: Fantini, Jacques, et al.
Publicado: (2021)

Leveraging coronavirus binding to gangliosides for innovative vaccine and therapeutic strategies against COVID-19
por: Fantini, Jacques, et al.
Publicado: (2021)

Host Membranes as Drivers of Virus Evolution
por: Matveeva, Mélanie, et al.
Publicado: (2023)

A Vaccine Strategy Based on the Identification of an Annular Ganglioside Binding Motif in Monkeypox Virus Protein E8L
por: Fantini, Jacques, et al.
Publicado: (2022)

Structural Dynamics of the SARS-CoV-2 Spike Protein: A 2-Year Retrospective Analysis of SARS-CoV-2 Variants (from Alpha to Omicron) Reveals an Early Divergence between Conserved and Variable Epitopes
por: Guérin, Patrick, et al.
Publicado: (2022)

The Epigenetic Dimension of Protein Structure Is an Intrinsic Weakness of the AlphaFold Program
por: Azzaz, Fodil, et al.
Publicado: (2022)

Electrostatic Surface Potential as a Key Parameter in Virus Transmission and Evolution: How to Manage Future Virus Pandemics in the Post-COVID-19 Era
por: Fantini, Jacques, et al.
Publicado: (2023)

AmyP53 Prevents the Formation of Neurotoxic β-Amyloid Oligomers through an Unprecedent Mechanism of Interaction with Gangliosides: Insights for Alzheimer’s Disease Therapy
por: Azzaz, Fodil, et al.
Publicado: (2023)

Anandamide Revisited: How Cholesterol and Ceramides Control Receptor-Dependent and Receptor-Independent Signal Transmission Pathways of a Lipid Neurotransmitter
por: Scala, Coralie Di, et al.
Publicado: (2018)

AmyP53, a Therapeutic Peptide Candidate for the Treatment of Alzheimer’s and Parkinson’s Disease: Safety, Stability, Pharmacokinetics Parameters and Nose-to Brain Delivery
por: Di Scala, Coralie, et al.
Publicado: (2022)

Comparison of the amyloid pore forming properties of rat and human Alzheimer’s beta-amyloid peptide 1-42: Calcium imaging data
por: Di Scala, Coralie, et al.
Publicado: (2016)

Common molecular mechanism of amyloid pore formation by Alzheimer’s β-amyloid peptide and α-synuclein
por: Di Scala, Coralie, et al.
Publicado: (2016)

Anandamide-ceramide interactions in a membrane environment: Molecular dynamic simulations data
por: Di Scala, Coralie, et al.
Publicado: (2017)

High Individual Heterogeneity of Neutralizing Activities against the Original Strain and Nine Different Variants of SARS-CoV-2
por: Jaafar, Rita, et al.
Publicado: (2021)

Gene Therapy Strategy for Alzheimer’s and Parkinson’s Diseases Aimed at Preventing the Formation of Neurotoxic Oligomers in SH-SY5Y Cells
por: El-Battari, Assou, et al.
Publicado: (2021)

Role of spike compensatory mutations in the interspecies transmission of SARS-CoV-2
por: Frutos, Roger, et al.
Publicado: (2022)

Molecular insights into amyloid regulation by membrane cholesterol and sphingolipids: common mechanisms in neurodegenerative diseases
por: Fantini, Jacques, et al.
Publicado: (2010)

Deciphering the Glycolipid Code of Alzheimer's and Parkinson's Amyloid Proteins Allowed the Creation of a Universal Ganglioside-Binding Peptide
por: Yahi, Nouara, et al.
Publicado: (2014)

How Cholesterol Constrains Glycolipid Conformation for Optimal Recognition of Alzheimer's β Amyloid Peptide (Aβ(1-40))
por: Yahi, Nouara, et al.
Publicado: (2010)

Cholesterol accelerates the binding of Alzheimer's β-amyloid peptide to ganglioside GM1 through a universal hydrogen-bond-dependent sterol tuning of glycolipid conformation
por: Fantini, Jacques, et al.
Publicado: (2013)

In vitro testing of combined hydroxychloroquine and azithromycin on SARS-CoV-2 shows synergistic effect
por: Andreani, Julien, et al.
Publicado: (2020)

First Detection of the SARS-CoV-2 Omicron BA.5/22B in Monaco
por: Colson, Philippe, et al.
Publicado: (2022)

Uncertain effects of hydroxychloroquine and azithromycin on SARS-Cov-2 viral load
por: Nguyen, Tuan V.
Publicado: (2021)

Limited spread of a rare spike E484K-harboring SARS-CoV-2 in Marseille, France
por: Colson, Philippe, et al.
Publicado: (2022)

Response to uncertain effect of hydroxychloroquine and azithromycin on SARS-CoV-2 viral load.
por: Gautret, Philippe, et al.
Publicado: (2021)

SARS-CoV-2 Persistent Viral Shedding in the Context of Hydroxychloroquine-Azithromycin Treatment
por: Drancourt, Michel, et al.
Publicado: (2021)

Emergence in southern France of a new SARS-CoV-2 variant harbouring both N501Y and E484K substitutions in the spike protein
por: Colson, Philippe, et al.
Publicado: (2022)

Effect of hydroxychloroquine and azithromycin on the viral clearance of SARS-CoV-2: response to Hervé Seligmann
por: Gautret, Philippe, et al.
Publicado: (2021)

Molecular docking analysis of azithromycin and hydroxychloroquine with spike surface glycoprotein of SARS-CoV-2
por: Singh, Jitender, et al.
Publicado: (2021)

In silico study of azithromycin, chloroquine and hydroxychloroquine and their potential mechanisms of action against SARS-CoV-2 infection
por: Braz, Helyson Lucas Bezerra, et al.
Publicado: (2020)

Azithromycin: Immunomodulatory and antiviral properties for SARS-CoV-2 infection
por: Khezri, Mohammad Rafi, et al.
Publicado: (2021)

Hydroxychloroquine- and azithromycin-related heart disorders
Publicado: (2020)

Hydroxychloroquine + azithromycin treatment in elderly patients
por: Gautret, Philippe, et al.
Publicado: (2021)

Hydroxychloroquine or chloroquine +/- azithromycin: heart disorders
Publicado: (2022)

Synergistic Adverse Effects of Azithromycin and Hydroxychloroquine on Human Cardiomyocytes at a Clinically Relevant Treatment Duration
por: Li, Wener, et al.
Publicado: (2022)

Reply to Gautret et al: hydroxychloroquine sulfate and azithromycin for COVID-19: what is the evidence and what are the risks?
por: Machiels, Julian D, et al.
Publicado: (2020)

QT interval prolongation with hydroxychloroquine plus azithromycin
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_peg8o4anribufj6pgn4scev0uh